Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$1.28B |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.02B |
| 3 |
Bank of America
BAC
|
+$770M |
| 4 |
Gilead Sciences
GILD
|
+$378M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$346M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.78B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$973M |
| 3 |
Walt Disney
DIS
|
+$588M |
| 4 |
Eli Lilly
LLY
|
+$569M |
| 5 |
AT&T
T
|
+$529M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.4% |
| 2 | Healthcare | 3.08% |
| 3 | Financials | 2.41% |
| 4 | Consumer Discretionary | 2.33% |
| 5 | Industrials | 1.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12876
CALL
KraneShares Global Carbon Strategy ETF
KRBN
$132M
| $21.5K | ﹤0.01% |
700
-6,700
| -91% | -$208K |
|
12877
CALL
ZK International Group
ZKIN
$60.8M
| $21.5K | ﹤0.01% |
5,257
+2,886
| +122% | +$14.7K |
|
12878
PUT
American Well
AMWL
$212M
| $21.5K | ﹤0.01% |
1,325
+865
| +188% | +$18.6K |
|
12879
Nano X Imaging
NNOX
$74.1M
| $21.4K | ﹤0.01% |
2,192
-72,546
| -97% | -$581K |
|
12880
CALL
SelectQuote
SLQT
$129M
| $21.4K | ﹤0.01% |
10,700
-29,100
| -73% | -$43.5K |
|
|
DRUG
12881
Bright Minds Biosciences
DRUG
$750M
| $21.4K | ﹤0.01% |
+17,829
| New | +$31.3K |
|
12882
INNOVATE Corp
VATE
$109M
| $21.4K | ﹤0.01% |
3,052
+1,705
| +127% | +$15K |
|
|
CMRC
12883
PUT
Commerce.com Inc Series 1
CMRC
$181M
| $21.4K | ﹤0.01% |
3,100
+1,300
| +72% | +$10.4K |
|
12884
PUT
OceanFirst Financial
OCFC
$1.91B
| $21.3K | ﹤0.01% |
1,300
-1,100
| -46% | -$17.7K |
|
12885
PUT
Primoris Services
PRIM
$4.48B
| $21.3K | ﹤0.01% |
500
-1,200
| -71% | -$44.3K |
|
12886
CALL
Comtech Telecommunications
CMTL
$52.7M
| $21.3K | ﹤0.01% |
6,200
-11,300
| -65% | -$70.9K |
|
12887
CALL
RAVE Restaurant Group
RAVE
$43.2M
| $21.2K | ﹤0.01% |
9,700
+1,200
| +14% | +$2.35K |
|
12888
CareCloud
CCLD
$110M
| $21.2K | ﹤0.01% |
+18,270
| New | +$24.6K |
|
|
BRFS
12889
CALL
DELISTED
BRF SA
BRFS
| $21.2K | ﹤0.01% |
6,500
-5,200
| -44% | -$15.3K |
|
|
APLT
12890
DELISTED
Applied Therapeutics
APLT
| $21.1K | ﹤0.01% |
3,109
-74,503
| -96% | -$334K |
|
12891
CALL
Gain Therapeutics
GANX
$90.4M
| $21.1K | ﹤0.01% |
5,600
+4,100
| +273% | +$17K |
|
|
FSP
12892
PUT
Franklin Street Properties
FSP
$50.8M
| $21.1K | ﹤0.01% |
9,300
+200
| +2% | +$477 |
|
12893
PUT
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.09M
| $21.1K | ﹤0.01% |
600
-50
| -8% | -$1.77K |
|
12894
CALL
Cerus
CERS
$601M
| $21K | ﹤0.01% |
11,100
+1,500
| +16% | +$3.06K |
|
12895
CALL
Lifetime Brands
LCUT
$226M
| $21K | ﹤0.01% |
2,000
+1,900
| +1,900% | +$16.7K |
|
12896
HeartCore Enterprises
HTCR
$3.75M
| $21K | ﹤0.01% |
1,080
-6
| -0.6% | -$83 |
|
12897
CALL
Bridgewater Bancshares
BWB
$620M
| $21K | ﹤0.01% |
1,800
+1,000
| +125% | +$12.2K |
|
12898
CALL
Flotek Industries
FTK
$1.3B
| $20.9K | ﹤0.01% |
5,600
+388
| +7% | +$1.24K |
|
12899
CALL
ASE Group
ASX
$103B
| $20.9K | ﹤0.01% |
1,900
-21,300
| -92% | -$209K |
|
12900
Entera Bio
ENTX
$500M
| $20.9K | ﹤0.01% |
+12,502
| New | +$13.8K |
|
Similar funds
Ken Griffin's Q1 2024 Portfolio in Review
As of Q1 2024, Ken Griffin held 15,912 positions worth $518B, up 3.6% from $500B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Griffin withdrew a net $36B in Q1 2024, closing 1,439 positions and reducing 6,148 holdings. Its most notable exit was iShares National Muni Bond ETF, an estimated $183M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.8% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Ken Griffin opened a new position in TD Synnex worth $245M.
- Ken Griffin's largest Q1 2024 buy was TD Synnex: 2,162,840 shares worth $245M.
- Ken Griffin added most to Hess in Q1 2024, an estimated $1.28B increase.
- Ken Griffin's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.78B.
- Ken Griffin fully exited iShares National Muni Bond ETF in Q1 2024, selling an estimated $183M.
- Ken Griffin's ten largest holdings make up 30% of its $518B portfolio in Q1 2024.
- Ken Griffin opened 1,749 new positions and closed 1,439 in Q1 2024.
- Ken Griffin's portfolio value rose 3.6% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.